GlassScriptPhysician profile
Sonia Ramamoorthy
NPI 1801812656
$130,976.88
in general payments reported to CMS, 2019-2025
22 companies · $32K in 2025
The $32K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $10K · 2021: $13K · 2022: $14K · 2023: $6,771 · 2024: $14K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Travel and Lodging: $7,657 · Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,070.00 |
| Travel and Lodging | $7,657.33 |
| Food and Beverage | $1,956.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $34,069.00 | 2021-2025 | Spy-Phi System, 1788, 1688 |
| Medical Device Business Services, INC. | $23,592.67 | 2019-2025 | |
| Medtronic, INC. | $21,029.28 | 2021-2025 | Signet, Eea, Signia |
| Covidien LP | $15,342.46 | 2019-2020 | |
| Arthrex, INC. | $11,031.80 | 2019-2025 | Arthrex |
| Ethicon INC. | $8,480.00 | 2025 | Contour |
| Ethicon US, LLC | $6,559.52 | 2019-2023 | Echelon; Endopath |
| Vertex Pharmaceuticals Incorporated | $3,900.00 | 2024 | |
| Intuitive Surgical, INC. | $3,100.93 | 2019-2023 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $1,375.00 | 2023 | |
| Medtronic USA, INC. | $1,000.40 | 2020 | |
| Heron Therapeutics, INC. | $750.00 | 2020 | |
| Conmed Corporation | $180.27 | 2023 | Airseal |
| Coloplast Corp | $159.98 | 2025 | |
| Cook Biotech Incorporated | $157.94 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $100.49 | 2022 | |
| Davol INC. | $41.04 | 2025 | Arista, Phasix Mesh |
| Olympus America INC. | $29.90 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.96 | 2022 | |
| Allergan, INC. | $19.91 | 2022 | |
| Boston Scientific Corporation | $16.33 | 2023 | |
| Convatec INC. | $16.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Ramamoorthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.